Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Quantifying the Effect of Posaconazole on Venetoclax Metabolism in Chinese Patients with Hematological Diseases

Lei Wang, Jian Cheng, Wenli Sun, Hai He, Meng Li, Yang Xue, Jing Xing, Tengkuan Wang, Hongxing Liu

Blood (2024) 144 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2024-200557

Published: 2024

Journal Articles

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Bian Renjie, Yi Qu, Danyang Wu, Jinxiang Yu, Xiaoxue Wang, Lei Wang, Juan He, Jun Wang, Xiaojing Yan

Blood (2024) 144 (Supplement 1): 6466.

https://doi.org/10.1182/blood-2024-204890

Published: 2024

Journal Articles

Diagnosis and Prognosis of aGVHD By Metabolic Biomarkers after Allogeneic Hematopoietic Stem Cell Transplantation

Lei Wang, Ruigeng Yang, Shufeng Li, Jiancheng Fang, Xiaofei Luo, Wenli Sun, Chunfei Jiang, Meng Li, Yang Xue, Hongxing Liu

Blood (2024) 144 (Supplement 1): 2148.

https://doi.org/10.1182/blood-2024-200509

Published: 2024

Journal Articles

Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform

Allison Barz Leahy, Jennifer Brogdon, Lucy Cain, Amanda M. Dinofia, Joseph A. Fraietta, Richard Hanna, Stephan Kadauke, Raabia Khan, Yimei Li, Shannon L. Maude, Regina M. Myers, Laura Shinehouse, Anna Sparrow, Melissa Varghese, Lei Wang, Yongping Wang, Stephan A. Grupp

Blood (2024) 144 (Supplement 1): 3470.

https://doi.org/10.1182/blood-2024-204300

Published: 2024

Journal Articles

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Rohith Jesudas, Lei Wang, Yan Chen, Sedigheh Mirzaei, Siddhant Taneja, Kirsten K Ness, Matthew J. Ehrhardt, Stephanie B Dixon, Bonnie Ky, Melissa M. Hudson, Clifford M. Takemoto, Daniel M. Green, Daniel A. Mulrooney

Blood (2024) 144 (Supplement 1): 698.

https://doi.org/10.1182/blood-2024-203521

Published: 2024

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li, Xianxuan Wang, Keyan Yang, Lei Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 599.

https://doi.org/10.1182/blood-2024-200684

Published: 2024

Journal Articles

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Keyan Yang, Lei Wang, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2024-200716

Published: 2024

Journal Articles

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Chuting Yang, Yaling Zheng, Chaoyang Song, Ming Wu, Lei Wang, Xuan Zhou, Chunyan Yue, Xiaonan Lin, Jie Chen, Hui Zeng, Rui Huang, Yuhua Li

Blood (2023) 142 (Supplement 1): 7045.

https://doi.org/10.1182/blood-2023-174879

Published: 2023

Journal Articles

Role of Ibea Gene in Hbmecs Invasion and Biofilm Formation Induced By Neonatal Meningitis Escherichia coli

Jimin Zhang, Qiongxi Lin, Lei Wang, Shaojie Yang, Xiaolong He, Liang Peng, Hong Cao

Blood (2023) 142 (Supplement 1): 5415.

https://doi.org/10.1182/blood-2023-185283

Published: 2023

Journal Articles

Efficacy and Safety of Orelabrutinib-Containing Regime (TORM) As First-Line Therapy in Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis

Shaojie Wu, Sanfang Tu, Zhenjun Zhou, Xinlin Sun, Anqin Wu, Lei Wang, Yuhua Li

Blood (2023) 142 (Supplement 1): 6322.

https://doi.org/10.1182/blood-2023-181471

Published: 2023

Journal Articles

Trametinib Maintenance in Patients with RAS Mutated Hematologic Malignancy Undergoing Allogeneic Haematopoietic Stem-Cell Transplantation: A Retrospective Transplant Study

Zhihui Li, Teng Xu, Xianxuan Wang, Xiaopei Wen, Lei Wang, Jingjing Wang, Tong Wu

Blood (2023) 142 (Supplement 1): 2212.

https://doi.org/10.1182/blood-2023-181425

Published: 2023

Journal Articles

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Zhihui Li, Qinlong Zheng, Keyan Yang, Teng Xu, Lei Wang, Xianxuan Wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2023) 142 (Supplement 1): 239.

https://doi.org/10.1182/blood-2023-180834

Published: 2023

Journal Articles

Characteristics of Central Nervous System Relapse after CD19 CAR-T Cell Therapy in R/R NHL

Mengyu Zhao, Tingting Yang, Yetian Dong, Wenxiao Li, Tianning Gu, Linghui Zhou, Jiazhen Cui, Wenfa Huang, Mingming Zhang, Lei Wang, Lixin Wang, Delin Kong, He Huang, Yongxian HU

Blood (2023) 142 (Supplement 1): 6915.

https://doi.org/10.1182/blood-2023-187951

Published: 2023

Journal Articles

Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b

Blood (2022) 140 (Supplement 1): 1606–1607.

https://doi.org/10.1182/blood-2022-167627

Published: 2022

Journal Articles

Central Nervous System Relapse after CAR-T Cell Therapy in B-Cell Malignancies

Tianning Gu, Wenfa Huang, Lei Wang, Yuqi Li, Lixin Wang, Yongxian Hu, He Huang

Blood (2022) 140 (Supplement 1): 13220–13221.

https://doi.org/10.1182/blood-2022-168477

Published: 2022

Journal Articles

The Aryl Hydrocarbon Receptor Defines a Unique Genomic and Immune Signature in AML Characterized By Monocytic Differentiation, Venetoclax Resistance and Is Targetable By Ahr Antagonist

Jennifer N. Saultz, Daniel Bottomly, Faith Burns, Kaelan Byrd, Yoko Kosaka, Shannon K. McWeeney, Stephen E. Kurtz, Guang Fan, Andy Kaempf, Karen McGovern, Lei Wang, Marta Sanchez-Martin, Dan S Kaufman, Evan F. Lind, Jeffrey W. Tyner

Blood (2022) 140 (Supplement 1): 3071–3072.

https://doi.org/10.1182/blood-2022-163166

Published: 2022

Journal Articles

Th22 and Tfh Cell Elevation Is Associated with Clinical Response of Photopheresis Therapy in Patients with Steroid-Refractory/ Resistant Graft-Versus-Host Disease (GvHD)

Yuntian Ding, Lei Wang, Ming Ni, Wenjie Gong, Sanmei Wang, Brigitte Neuber, Maria-Luisa Schubert, Tim Sauer, Angela Hückelhoven-Krauss, Thomas Luft, Ute Hegenbart, Stefan Schönland, Volker Eckstein, Jishi Wang, William Hermann Krüger, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt

Blood (2021) 138 (Supplement 1): 1810.

https://doi.org/10.1182/blood-2021-150106

Published: 2021

Journal Articles

Third-Generation Chimeric Antigen Receptor (CAR) T Cells in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL) - Results from the Heidelberg Trial 1 (HD-CAR-1 trial)

Maria-Luisa Schubert, Anita Schmitt, Brigitte Neuber, Angela Hückelhoven-Krauss, Alexander Kunz, Lei Wang, Birgit Michels, Philip Waldhoff, Leopold Sellner, Felix Korell, Susanne Hofmann, Petra Pavel, Anthony D Ho, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt

Blood (2021) 138 (Supplement 1): 1734.

https://doi.org/10.1182/blood-2021-152028

Published: 2021

Journal Articles

Aryl Hydrocarbon Receptor (AHR) Gene Expression in AML Is Associated with FLT3-ITD+ AML and HLA-E Induced Immune Resistance Reversed By Ik-364

Jennifer N. Saultz, Evan F. Lind, Jeffrey W. Tyner, Kaelan Byrd, Shannon K. McWeeney, Yoko Kosaka, Karen McGovern, Lei Wang, Marta Sanchez-Martin

Blood (2021) 138 (Supplement 1): 1161.

https://doi.org/10.1182/blood-2021-147589

Published: 2021

Journal Articles

Impact of SAMHD1 Pharmacogenetics on Clinical Outcome in Pediatric AML

Richard J Marrero, Abdelrahman H Elsayed, Xueyuan Cao, Huiyun Wu, Lei Wang, Raul C Ribeiro, Jeffrey E. Rubnitz, Stanley B Pounds, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 3429.

https://doi.org/10.1182/blood-2021-147528

Published: 2021

NARROW

Quantifying the Effect of Posaconazole on Venetoclax Metabolism in Chinese Patients with Hematological Diseases

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Diagnosis and Prognosis of aGVHD By Metabolic Biomarkers after Allogeneic Hematopoietic Stem Cell Transplantation

Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Role of Ibea Gene in Hbmecs Invasion and Biofilm Formation Induced By Neonatal Meningitis Escherichia coli

Efficacy and Safety of Orelabrutinib-Containing Regime (TORM) As First-Line Therapy in Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis

Trametinib Maintenance in Patients with RAS Mutated Hematologic Malignancy Undergoing Allogeneic Haematopoietic Stem-Cell Transplantation: A Retrospective Transplant Study

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Characteristics of Central Nervous System Relapse after CD19 CAR-T Cell Therapy in R/R NHL

Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b

Central Nervous System Relapse after CAR-T Cell Therapy in B-Cell Malignancies

The Aryl Hydrocarbon Receptor Defines a Unique Genomic and Immune Signature in AML Characterized By Monocytic Differentiation, Venetoclax Resistance and Is Targetable By Ahr Antagonist

Th22 and Tfh Cell Elevation Is Associated with Clinical Response of Photopheresis Therapy in Patients with Steroid-Refractory/ Resistant Graft-Versus-Host Disease (GvHD)

Third-Generation Chimeric Antigen Receptor (CAR) T Cells in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL) - Results from the Heidelberg Trial 1 (HD-CAR-1 trial)

Aryl Hydrocarbon Receptor (AHR) Gene Expression in AML Is Associated with FLT3-ITD+ AML and HLA-E Induced Immune Resistance Reversed By Ik-364

Impact of SAMHD1 Pharmacogenetics on Clinical Outcome in Pediatric AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only